Aspirin for benign prostatic hyperplasia : studying the effect on flow-rate by a self-designed flowmeter

Abstract EN

Objective : The study was conducted to determine the effect of acetylsalicylic acidor commercially called (Aspirin) on the flow rate of patients with benign prostatic hyperplasia by the use of a self-designed flowmeter. Materials and Methods: This was a prospective study between May 2007 and September 2015, evaluating the effect of Aspirin 100 mg in patients with benign prostatic hyperplasia on prostate symptom score and the maximum flow rate, using a flowmeter designed and assembled by the author.

The total number of patients completed the study was 1338 patient, they were all assessed and flow rate measured both before given Aspirin and after one-year time. Results : The international prostate symptom score had a reduction in its mean from15.431 ±2.665 SD to14.352±2.455 SD after one year of taking Aspirin, the maximum flow rate was increased from7.66ml/sec ± 1.63 SD to9.26 ml/sec ± 1.96 SD in the same period. Conclusion: Aspirin is effective in reducing the symptom score of patients with benign prostatic hyperplasia and improve the flowrate in such patients, using the economical self-designed and assembled flowmeter